CoChat

Blood-based biomarkers predicting response to antidepressants

Busch, Yasmin, Menke, Andreas · 2019 · Journal of Neural Transmission
Cited by 27

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00702-018-1844-x

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 133

  1. Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L (2006) Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord 90(2–3):251–256 (PubMed PMID: 16356553) · DOI
  2. Arias B, Fabbri C, Gressier F, Serretti A, Mitjans M, Gasto C et al (2013) TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology 67(1):41–47 (PubMed PMID: 23221997, Epub 2012/12/12.eng) · DOI
  3. Aschbacher K, Mills PJ, von Kanel R, Hong S, Mausbach BT, Roepke SK et al (2008) Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 22(4):493–502 (PubMed PMID: 18054198, Pubmed Central PMCID: 2442159) · DOI
  4. Baffa A, Hohoff C, Baune BT, Muller-Tidow C, Tidow N, Freitag C et al (2010) Norepinephrine and serotonin transporter genes: impact on treatment response in depression. Neuropsychobiology 62(2):121–131 (PubMed PMID: 20588071) · DOI · Paper page
  5. Barron E, Lara J, White M, Mathers JC (2015) Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PloS One 10(6):e0127550 (PubMed PMID: 26039142, Pubmed Central PMCID: 4454670) · DOI · Paper page
  6. Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K (2008) Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 436(2):111–115 (PubMed PMID: 18387740, Epub 2008/04/05.eng) · DOI
  7. Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P et al (2010) The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67(6):543–549 (PubMed PMID: 20044070, Epub 2010/01/02.eng) · DOI · Paper page
  8. Bleys D, Luyten P, Soenens B, Claes S (2018) Gene–environment interactions between stress and 5-HTTLPR in depression: a meta-analytic update. J Affect Disord 15(226):339–345 (PubMed PMID: 29031184) · DOI
  9. Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C et al (2000) Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am J Med Genet 96(6):831–835 (PubMed PMID: 11121191) · DOI · Paper page
  10. Bortolozzi A, Castane A, Semakova J, Santana N, Alvarado G, Cortes R et al (2012) Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry 17(6):612–623 (PubMed PMID: 21808255, Epub 2011/08/03.eng) · DOI
  11. Bozina N, Peles AM, Sagud M, Bilusic H, Jakovljevic M (2008) Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder. World J Biol Psychiatry 9(3):190–197 (PubMed PMID: 17853254, Epub 2007/09/14.eng) · DOI · Paper page
  12. Breitenstein B, Bruckl TM, Ising M, Muller-Myhsok B, Holsboer F, Czamara D (2015) ABCB1 gene variants and antidepressant treatment outcome: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 168B(4):274–283 (PubMed PMID: 25847751) · DOI · Paper page
  13. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L (2009) Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 119(1–3):107–115 (PubMed PMID: 19339052, Epub 2009/04/03.eng) · DOI
  14. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389 (PubMed PMID: 12869766) · DOI · Paper page
  15. Cattaneo A, Pariante CM (2018) Integrating ‘Omics’ approaches to prioritize new pathogenetic mechanisms for mental disorders. Neuropsychopharmacology 43(1):227–228 (PubMed PMID: 29192656, Pubmed Central PMCID: PMC5719117) · DOI
  16. Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA, Gennarelli M (2010a) The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 35(7):1423–1428 (PubMed PMID: 20164831, Pubmed Central PMCID: PMC3055467, Epub 2010/02/19.eng) · DOI
  17. Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M (2010b) Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol 13(1):103–108 (PubMed PMID: 19835669, Epub 2009/10/20.eng) · DOI · Paper page
  18. Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158(5):748–753 (PubMed PMID: 11329397, Epub 2001/05/01.eng) · DOI · Paper page
  19. Crissman AM, Makhay MM, O’Donnell JM (2001) Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors. Psychopharmacology 154(1):70–75 (PubMed PMID: 11292008, Epub 2001/04/09.eng) · DOI
  20. Crowley JJ, Lipsky RH, Lucki I, Berrettini WH (2008) Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome. Psychiatr Genet 18(5):248–251 (PubMed PMID: 18797399, Epub 2008/09/18.eng) · DOI
  21. Culverhouse RC, Saccone NL, Horton AC, Ma Y, Anstey KJ, Banaschewski T et al (2018) Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry 23(1):133–142 (PubMed PMID: 28373689, Pubmed Central PMCID: PMC5628077) · DOI · Paper page
  22. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R et al (2002) Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol 5(1):27–35 (PubMed PMID: 12057029) · DOI · Paper page
  23. de Klerk OL, Nolte IM, Bet PM, Bosker FJ, Snieder H, den Boer JA et al (2013) ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. Pharmacogenom J 13(4):349–353 (PubMed PMID: 22641028, Epub 2012/05/30.eng) · DOI
  24. de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6(6):463–475 (PubMed PMID: 15891777) · DOI · Paper page
  25. Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V et al (2008) Monoamine oxidase A variant influences antidepressant treatment response in female patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32(1):224–228 (PubMed PMID: 17884271, Epub 2007/09/22.eng) · DOI
  26. Dong C, Wong ML, Licinio J (2009) Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican–Americans. Mol Psychiatry 14(12):1105–1118 (PubMed PMID: 19844206, Pubmed Central PMCID: PMC2834349, Epub 2009/10/22.eng) · DOI · Paper page
  27. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–457 (PubMed PMID: 20015486) · DOI · Paper page
  28. Dreimuller N, Tadic A, Dragicevic A, Boland K, Bondy B, Lieb K et al (2012) The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression. Pharmacopsychiatry 45(3):108–113 (PubMed PMID: 22086748, Epub 2011/11/17.eng) · doi:10.1055/s-0031-1291347
  29. Eichelbaum M, Fromm MF, Schwab M (2004) Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 26(2):180–185 (PubMed PMID: 15228162, Epub 2004/07/02.eng) · DOI · Paper page
  30. Fabbri C, Di Girolamo G, Serretti A (2013) Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. Am J Med Genet Part B Neuropsychiatr Genet 162B(6):487–520 (PubMed PMID: 23852853, Epub 2013/07/16.eng) · DOI · Paper page
  31. Fernandes BS, Berk M, Turck CW, Steiner J, Goncalves CA (2014) Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry 19(7):750–751 (PubMed PMID: 24342989) · DOI · Paper page
  32. Fiskerstrand CE, Lovejoy EA, Quinn JP (1999) An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458(2):171–174 (PubMed PMID: 10481059, Epub 1999/09/11.eng) · DOI · Paper page
  33. Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, Zhu W et al (2007) Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry 62(4):355–358 (PubMed PMID: 17141746, Epub 2006/12/05.eng) · DOI
  34. Garriock HA, Delgado P, Kling MA, Carpenter LL, Burke M, Burke WJ et al (2006) Number of risk genotypes is a risk factor for major depressive disorder: a case control study. Behav Brain Funct 2:24 (PubMed PMID: 16822313, Pubmed Central PMCID: PMC1526442, Epub 2006/07/11.eng) · DOI · Paper page
  35. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD et al (2010) A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67(2):133–138 (PubMed PMID: 19846067, Epub 2009/10/23.eng) · DOI · Paper page
  36. Geracitano R, Federici M, Bernardi G, Mercuri NB (2006) On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons. Ann N Y Acad Sci 1074:320–329 (PubMed PMID: 17105928, Epub 2006/11/16.eng) · DOI
  37. Gillman PK (2007) Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151(6):737–748 (PubMed PMID: 17471183, Pubmed Central PMCID: PMC2014120, Epub 2007/05/02.eng) · DOI · Paper page
  38. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test–retest reproducibility. Arch Gen Psychiatry 40(5):493–500 (PubMed PMID: 6340634, Epub 1983/05/01.eng) · DOI · Paper page
  39. Hahn MK, Mazei-Robison MS, Blakely RD (2005) Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 68(2):457–466 (PubMed PMID: 15894713, Epub 2005/05/17.eng) · DOI
  40. Hennings JM, Uhr M, Klengel T, Weber P, Putz B, Touma C et al (2015) RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Transl Psychiatry 5:e538 (PubMed PMID: 25826113, Pubmed Central PMCID: 4429173) · DOI · Paper page
  41. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23(5):477–501 (PubMed PMID: 11027914) · DOI · Paper page
  42. Holsboer F, Ising M (2008) Central CRH system in depression and anxiety–evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583(2–3):350–357 (PubMed PMID: 18272149, Epub 2008/02/15.eng) · DOI · Paper page
  43. Hong CJ, Chen TJ, Yu YW, Tsai SJ (2006) Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenom J 6(1):27–33 (PubMed PMID: 16302021) · DOI · Paper page
  44. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 78(5):815–826 (PubMed PMID: 16642437) · DOI · Paper page
  45. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ et al (2007) Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 64(7):783–792 (PubMed PMID: 17606812) · DOI · Paper page
  46. Hwu HG, Chen TY, Yang YY (1985) The clinical diagnostic value of dexamethasone suppression test in depressive illness. Ann Acad Med Singap 14(1):104–109 (PubMed PMID: 4004115, Epub 1985/01/01.eng)
  47. Ide S, Kakeda S, Watanabe K, Yoshimura R, Abe O, Hayashi K et al (2015) Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: a VBM analysis of brain MRI. Psychiatry Res 233(2):120–124 (PubMed PMID: 26078197, Epub 2015/06/17. eng) · DOI
  48. Illi A, Setala-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N et al (2009) 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 20(12):1125–1128 (PubMed PMID: 19590397, Epub 2009/07/11.eng) · DOI · Paper page
  49. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S et al (2009) A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66(9):966–975 (PubMed PMID: 19736353, Epub 2009/09/09.eng) · DOI · Paper page
  50. Jetten AM (2004) Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy 3(4):395–412 (PubMed PMID: 15584888) · DOI · Paper page
  51. Ji Y, Biernacka J, Snyder K, Drews M, Pelleymounter LL, Colby C et al (2012) Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. Pharmacogenom J 12(1):78–85 (PubMed PMID: 20877297, Pubmed Central PMCID: PMC3113454, Epub 2010/09/30.eng) · DOI
  52. Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87(2–3):305–311 (PubMed PMID: 15951024, Epub 2005/06/14.eng) · DOI · Paper page
  53. Kang RH, Choi MJ, Paik JW, Hahn SW, Lee MS (2007) Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression. Int J Psychiatry Med 37(3):315–329 (PubMed PMID: 18314859, Epub 2008/03/05.eng) · DOI
  54. Kato M, Fukuda T, Wakeno M, Fukuda K, Okugawa G, Ikenaga Y et al (2006) Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 53(4):186–195 (PubMed PMID: 16874005) · DOI · Paper page
  55. Kato M, Wakeno M, Okugawa G, Fukuda T, Azuma J, Kinoshita T et al (2007) No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression. Neuropsychobiology 56(4):167–171 (PubMed PMID: 18332644, Epub 2008/03/12.eng) · DOI
  56. Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y et al (2008) ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32(2):398–404 (PubMed PMID: 17913323, Epub 2007/10/05.eng) · DOI · Paper page
  57. Kato M, Fukuda T, Wakeno M, Okugawa G, Takekita Y, Watanabe S et al (2009) Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet Part B Neuropsychiatr Genet 150B(1):115–123 (PubMed PMID: 18484082, Epub 2008/05/17.eng) · DOI · Paper page
  58. Katz ER, Stowe ZN, Newport DJ, Kelley ME, Pace TW, Cubells JF et al (2012) Regulation of mRNA expression encoding chaperone and co-chaperone proteins of the glucocorticoid receptor in peripheral blood: association with depressive symptoms during pregnancy. Psychol Med 42(5):943–956 (PubMed PMID: 21995950, Epub 2011/10/15.eng) · DOI
  59. Kautzky A, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J et al (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression. Eur Neuropsychopharmacol 25(4):441–453 (PubMed PMID: 25769916, Epub 2015/03/15.eng) · DOI
  60. Keers R, Aitchison KJ (2010) Gender differences in antidepressant drug response. Int Rev Psychiatry (Abingdon, England) 22(5):485–500 (PubMed PMID: 21047161, Epub 2010/11/05.eng) · DOI · Paper page
  61. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG et al (2000) Serotonin transporter gene polymorphism and antidepressant response. NeuroReport 11(1):215–219 (PubMed PMID: 10683861) · DOI · Paper page
  62. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ et al (2006) Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296(13):1609–1618 (PubMed PMID: 17018806) · DOI · Paper page
  63. Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockmoller J (2007) A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenom J 7(1):48–55 (PubMed PMID: 16702979) · DOI
  64. Koob GF, Zorrilla EP (2012) Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology 37(1):308–309 (PubMed PMID: 22157874, Pubmed Central PMCID: PMC3238086, Epub 2011/12/14.eng) · DOI
  65. Kovacs D, Eszlari N, Petschner P, Pap D, Vas S, Kovacs P et al (2016) Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress. Brain Behav Immun (PubMed PMID: 26891860, Epub 2016/02/20.eng) · DOI · Paper page
  66. Kovacs D, Eszlari N, Petschner P, Pap D, Vas S, Kovacs P et al (2016b) Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes. J Neural Transm (Vienna, Austria: 1996) 123(5):541–548 (PubMed PMID: 26821321, Pubmed Central PMCID: PMC4846685, Epub 2016/01/29.eng) · DOI
  67. Kraft JB, Slager SL, McGrath PJ, Hamilton SP (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58(5):374–381 (PubMed PMID: 15993855) · DOI · Paper page
  68. Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ et al (2007) Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 61(6):734–742 (PubMed PMID: 17123473) · DOI
  69. Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T et al (1997) Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2(6):457–462 (PubMed PMID: 9399688) · DOI · Paper page
  70. Laika B, Leucht S, Steimer W (2006) ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline. Clin Chem 52(5):893–895 (PubMed PMID: 16638956) · DOI · Paper page
  71. Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004) Association of the C(−1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 7(4):501–506 (PubMed PMID: 15447813) · DOI · Paper page
  72. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531 (PubMed PMID: 8929413) · DOI · Paper page
  73. Licinio J, O’Kirwan F, Irizarry K, Merriman B, Thakur S, Jepson R et al (2004) Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican–Americans. Mol Psychiatry 9(12):1075–1082 (PubMed PMID: 15365580) · DOI · Paper page
  74. Lifschytz T, Gur E, Lerer B, Newman ME (2004) Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140(1–2):133–139 (PubMed PMID: 15589343, Epub 2004/12/14.eng) · DOI
  75. Lin JY, Jiang MY, Kan ZM, Chu Y (2014) Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis. J Affect Disord 168:430–438 (PubMed PMID: 25108775) · DOI
  76. Lisiecka DM, O’Hanlon E, Fagan AJ, Carballedo A, Morris D, Suckling J et al (2015) BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls. J Affect Disord 184:239–244 (PubMed PMID: 26117067, Epub 2015/06/29.eng) · DOI
  77. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al (2005) Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s disease. Am J Med Genet Part B Neuropsychiatr Genet 134B(1):93–103 (PubMed PMID: 15666411, Epub 2005/01/25.eng) · DOI · Paper page
  78. Lopizzo N, Tosato S, Begni V, Tomassi S, Cattane N, Barcella M et al (2017) Transcriptomic analyses and leukocyte telomere length measurement in subjects exposed to severe recent stressful life events. Transl Psychiatry 7(2):e1042 (PubMed PMID: 28221367, Pubmed Central PMCID: PMC5438034) · DOI
  79. MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96(26):15251–15255 (PubMed PMID: 10611371, Pubmed Central PMCID: PMC24806, Epub 1999/12/28.eng) · DOI · Paper page
  80. Mandelli L, Mazza M, Martinotti G, Tavian D, Colombo E, Missaglia S et al (2010) Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J Psychopharmacol (Oxford, England) 24(12):1747–1754 (PubMed PMID: 20142305, Epub 2010/02/10. eng) · DOI
  81. Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ et al (2009) Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. Eur Neuropsychopharmacol 19(6):451–456 (PubMed PMID: 19272758, Epub 2009/03/11.eng) · DOI
  82. Min W, Li T, Ma X, Li Z, Yu T, Gao D et al (2009) Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Psychopharmacology 205(3):409–417 (PubMed PMID: 19468717, Epub 2009/05/27.eng) · DOI
  83. Murphy DL, Lerner A, Rudnick G, Lesch KP (2004a) Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4(2):109–123 (PubMed PMID: 15087484, Epub 2004/04/17.eng) · DOI · Paper page
  84. Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004b) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61(11):1163–1169 (PubMed PMID: 15520364) · DOI · Paper page
  85. Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E (2007) Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry 61(2):167–173 (PubMed PMID: 16697352, Epub 2006/05/16.eng) · DOI
  86. Nakamura K, Hasegawa H (2007) Developmental role of tryptophan hydroxylase in the nervous system. Mol Neurobiol 35(1):45–54 (PubMed PMID: 17519505, Epub 2007/05/24.eng) · DOI
  87. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997) Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45(1):145–148 (PubMed PMID: 9105682, Epub 1997/04/01.eng) · DOI · Paper page
  88. Niitsu T, Fabbri C, Bentini F, Serretti A (2013) Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 1(45):183–194 (PubMed PMID: 23733030) · DOI · Paper page
  89. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM et al (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet (London, England) 347(9003):731–733 (PubMed PMID: 8602004, Epub 1996/03/16.eng) · DOI · Paper page
  90. Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J et al (2012) Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry 2:e101 (PubMed PMID: 22832901, Epub 2012/07/27.eng) · DOI · Paper page
  91. Pandey DK, Mahesh R, Kumar AA, Rao VS, Arjun M, Rajkumar R (2010a) A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol Biochem Behav 94(3):363–373 (PubMed PMID: 19800913, Epub 2009/10/06.eng) · DOI
  92. Papiol S, Arias B, Gasto C, Gutierrez B, Catalan R, Fananas L (2007) Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. J Affect Disord 104(1–3):83–90 (PubMed PMID: 17467808, Epub 2007/05/01.eng) · DOI · Paper page
  93. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ (2006) Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31(8):1745–1749 (PubMed PMID: 16395308, Epub 2006/01/06.eng) · DOI · Paper page
  94. Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM et al (2003) Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 54(9):879–883 (PubMed PMID: 14573314) · DOI · Paper page
  95. Perlis RH, Fijal B, Dharia S, Heinloth AN, Houston JP (2010) Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients. Biol Psychiatry 67(11):1110–1113 (PubMed PMID: 20110084, Epub 2010/01/30.eng) · DOI
  96. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP (2004) Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 9(9):879–889 (PubMed PMID: 15052272) · DOI · Paper page
  97. Peters EJ, Slager SL, Kraft JB, Jenkins GD, Reinalda MS, McGrath PJ et al (2008) Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PloS One 3(4):e1872 (PubMed PMID: 18382661, Pubmed Central PMCID: PMC2268970, Epub 2008/04/03.eng) · DOI · Paper page
  98. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H et al (2010) Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 13(4):535–539 (PubMed PMID: 19941699) · DOI · Paper page
  99. Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A (2011) Pharmacogenetics of antidepressant response. J Psychiatry Neurosci 36(2):87–113 (PubMed PMID: 21172166, Pubmed Central PMCID: PMC3044192, Epub 2010/12/22.eng) · DOI · Paper page
  100. Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T et al (2013) Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur Neuropsychopharmacol 23(9):1105–1114 (PubMed PMID: 23142150, Epub 2012/11/13.eng) · DOI
  101. Ray A, Tennakoon L, Keller J, Sarginson JE, Ryan HS, Murphy GM et al (2015) ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. Pharmacogenom J 15(4):332–339 (PubMed PMID: 25487678, Epub 2014/12/10.eng) · DOI
  102. Ruhe HG, Ooteman W, Booij J, Michel MC, Moeton M, Baas F et al (2009) Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder. Pharmacogenet Genom 19(1):67–76 (PubMed PMID: 18987562, Epub 2008/11/07.eng) · DOI · Paper page
  103. Sarginson JE, Lazzeroni LC, Ryan HS, Ershoff BD, Schatzberg AF, Murphy GM Jr (2010) ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenet Genom 20(8):467–475 (PubMed PMID: 20555295, Epub 2010/06/18.eng) · DOI · Paper page
  104. Sartorius N (2001) The economic and social burden of depression. J Clin Psychiatry 62(Suppl 15):8–11 (PubMed PMID: 11444765, Epub 2001/07/11.eng)
  105. Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM Jr, Williams LM (2015) ABCB1 genetic effects on antidepressant outcomes: a report from the iSPOT-D trial. Am J Psychiatry 172(8):751–759 (PubMed PMID: 25815420, Epub 2015/03/31.eng) · DOI · Paper page
  106. Serretti A, Artioli P (2004) The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenom J 4(4):233–244 (PubMed PMID: 15111987, Epub 2004/04/28.eng) · DOI
  107. Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E (2001) Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol 11(5):375–380 (PubMed PMID: 11597824) · DOI
  108. Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R (2004) The C(−1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 7(4):453–460 (PubMed PMID: 15458611) · DOI · Paper page
  109. Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217 (PubMed PMID: 10202537, Pubmed Central PMCID: PMC2844879, Epub 1999/04/15.eng) · DOI · Paper page
  110. Shiroma PR, Drews MS, Geske JR, Mrazek DA (2014) SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a sequenced treatment alternatives to relieve depression (STAR*D) report. Am J Geriatr Psychiatry 22(11):1140–1148 (PubMed PMID: 23973251, Pubmed Central PMCID: PMC4358736, Epub 2013/08/27.eng) · DOI
  111. Smith AJ, Sketris I, Cooke C, Gardner D, Kisely S, Tett SE (2008) A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf 17(7):697–706 (PubMed PMID: 18181227, Epub 2008/01/09.eng) · DOI
  112. Smits K, Smits L, Peeters F, Schouten J, Janssen R, Smeets H et al (2007) Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 22(3):137–143 (PubMed PMID: 17414739, Epub 2007/04/07.eng) · DOI · Paper page
  113. Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E (2011) An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J Affect Disord 128(1–2):41–48 (PubMed PMID: 20619899, Epub 2010/07/14.eng) · DOI
  114. Spurlock G, Heils A, Holmans P, Williams J, D’Souza UM, Cardno A et al (1998) A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 3(1):42–49 (PubMed PMID: 9491812, Epub 1998/03/10.eng) · DOI · Paper page
  115. Suzuki Y, Sawamura K, Someya T (2004) The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients. Pharmacogenom J 4(4):283–286 (PubMed PMID: 15148501) · DOI
  116. Szegedi A, Rujescu D, Tadic A, Muller MJ, Kohnen R, Stassen HH et al (2005) The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenom J 5(1):49–53 (PubMed PMID: 15520843) · DOI
  117. Tadic A, Muller MJ, Rujescu D, Kohnen R, Stassen HH, Dahmen N et al (2007) The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet Part B Neuropsychiatr Genet 144B(3):325–331 (PubMed PMID: 17192957, Epub 2006/12/29.eng) · DOI · Paper page
  118. Tsai SJ, Hong CJ, Chen TJ, Yu YW (2007) Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment. Am J Med Genet B Neuropsychiatr Genet 144(8):1097–1098 (PubMed PMID: 17721930, Epub 2007/08/28.eng) · DOI
  119. Udina M, Moreno-Espana J, Navines R, Gimenez D, Langohr K, Gratacos M et al (2013) Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 38(9):1803–1813 (PubMed PMID: 23571152, Epub 2013/04/11.eng) · DOI
  120. Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W et al (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167(5):555–564 (PubMed PMID: 20360315, Epub 2010/04/03.eng) · DOI · Paper page
  121. Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J et al (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171(12):1278–1286 (PubMed PMID: 25017001) · DOI · Paper page
  122. Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M et al (2008) Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57(2):203–209 (PubMed PMID: 18215618, Epub 2008/01/25.eng) · DOI · Paper page
  123. van Rossum EF, Binder EB, Majer M, Koper JW, Ising M, Modell S et al (2006) Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry 59(8):681–688 (PubMed PMID: 16580345) · DOI · Paper page
  124. Villafuerte SM, Vallabhaneni K, Sliwerska E, McMahon FJ, Young EA, Burmeister M (2009) SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatr Genet 19(6):281–291 (PubMed PMID: 19829169, Pubmed Central PMCID: PMC2783179, Epub 2009/10/16.eng) · DOI · Paper page
  125. Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK et al (2011) TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology 213(4):773–779 (PubMed PMID: 20945066, Epub 2010/10/15.eng) · DOI
  126. Wang Y, Liu X, Yu Y, Han Y, Wei J, Collier D et al (2012) The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment. Psychiatry Res 200(2–3):1047–1050 (PubMed PMID: 22796099, Epub 2012/07/17.eng) · DOI
  127. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K et al (2004) Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 161(9):1575–1580 (PubMed PMID: 15337646) · DOI · Paper page
  128. Yoshida K, Higuchi H, Takahashi H, Kamata M, Sato K, Inoue K et al (2008) Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran. Hum Psychopharmacol 23(2):121–128 (PubMed PMID: 18023073, Epub 2007/11/21.eng) · DOI · Paper page
  129. Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ (2006) Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 16(7):498–503 (PubMed PMID: 16458487) · DOI
  130. Zakharyan R, Petrek M, Arakelyan A, Mrazek F, Atshemyan S, Boyajyan A (2012) Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. Tissue Antigens 80(2):136–142 (PubMed PMID: 22571276, Epub 2012/05/11.eng) · DOI
  131. Zhao X, Huang Y, Li J, Ma H, Jin Q, Wang Y et al (2012) Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis. Int Clin Psychopharmacol 27(6):314–320 (PubMed PMID: 22890315, Epub 2012/08/15.eng)
  132. Zorrilla EP, Heilig M, de Wit H, Shaham Y (2013) Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128(3):175–186 (PubMed PMID: 23294766, Pubmed Central PMCID: PMC3596012, Epub 2013/01/09.eng) · DOI · Paper page
  133. Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH et al (2010) Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61(2):71–78 (PubMed PMID: 20016225, Epub 2009/12/18.eng) · DOI · Paper page

Cited by

See all 27

Metadata

Authors
Busch, Y., & Menke, A.
Venue
Journal of Neural Transmission
Published
2018-01-27
Volume
126
Issue
1
Pages
47-63
ISSN
  • 0300-9564
  • 1435-1463
Cited by
27
References
57
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-based biomarkers predicting response to antidepressants. https://app.cochat.ai/papers/10.1007/s00702-018-1844-x
The paper
Busch, Y., & Menke, A. (2019). Blood-based biomarkers predicting response to antidepressants. Journal of Neural Transmission. https://doi.org/10.1007/s00702-018-1844-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.